AAV-MyoAAV 4A Rep-Cap plasmid (serotype MyoAAV 4A - specific AAV RC-MyoAAV 4A plasmids)
GeneMedi's MyoAAV 4A Rep-Cap plasmid supplies the AAV2 Rep (replication) proteins and the MyoAAV 4A capsid protein.
You can produce MyoAAV 4A particle in 293T cell line in high titer using GeneMedi's MyoAAV 4A Rep-Cap plasmid with GM's AAV expression vector (overexpression or shRNA) and AAV helper plasmid.
Product Description
Cat.NO | Product Name | Organization Type | Price(In USD) | Qty (Quantity) | Sum(In USD) |
---|---|---|---|---|---|
P-RC33 | AAV-MyoAAV 4A Rep-Cap Plasmid | Academic | 2062 | ||
P-RC33 | AAV-MyoAAV 4A Rep-Cap Plasmid | Industry R&D (excluding CRO&CDMO&CXO) |
|||
P-RC33 | AAV-MyoAAV 4A Rep-Cap Plasmid | CRO&CDMO& CXO&CMC& Manufacturing company |
|||
P-PK33 | AAV-MyoAAV 4A Vector
System
1. MyoAAV 4A Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug |
Academic | 3379 | ||
P-PK33 | AAV-MyoAAV 4A Vector
System
1. MyoAAV 4A Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | Industry R&D (excluding CRO&CDMO&CXO) |
|||
P-PK33 | AAV-MyoAAV 4A Vector
System
1. MyoAAV 4A Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | CRO&CDMO& CXO&CMC& Manufacturing company |
|||
If you want to obtain higher quantities of plasmids (mg), please visit GM TransExcellent Plasmid DNA Rapid Preparation Service. | |||||
Shipping Cost: | 169.00 | ||||
Total: | |||||
Citation
Title | Publication | Date |
---|---|---|
TRIB3 Promotes APL Progression through Stabilization of the Oncoprotein PML-RARa and Inhibition of p53-Mediated Senescence | Cancer Cell | 2017/5/8 |
Laterodorsal tegmentum interneuron subtypes oppositely regulate olfactory cue-induced innate fear | NATURE NEUROSCIENCE | 2016/6/26 |
HACE1-mediated NRF2 activation causes enhanced malignant phenotypes and decreased radiosensitivity of glioma cells | Signal Transduction and Targeted Therapy | 2021/11/24 |
Genetic and Pharmacological Inhibition of Astrocytic Mysm1 Alleviates Depressive‐Like Disorders by Promoting ATP Production | Advanced Science | 2022/11/22 |
Skin chronological aging drives age-related bone loss via secretion of cystatin-A | Nature Aging | 2022/10/6 |
Metabolite asymmetric dimethylarginine (ADMA) functions as a destabilization enhancer of SOX9 mediated by DDAH1 in osteoarthritis | Science Advances | 2023/2/8 |
Capturing dynamic biological signals via bio-mimicking hydrogel for precise remodeling of soft tissue | Bioactive Materials | 2021/5/11 |
A novel circular RNA, circIgfbp2, links neural plasticity and anxiety through targeting mitochondrial dysfunction and oxidative stress-induced synapse dysfunction after traumatic brain injury | Molecular Psychiatry | 2022/8/2 |
Extracellular vesicle-derived CircWhsc1 Promotes Cardiomyocyte Proliferation and Heart Repair by activating TRIM59/STAT3/Cyclin B2 pathway | Journal of Advanced Research | 2022/12/29 |
Circular RNA CREBBP modulates cartilage degradation by activating the Smad1/5 pathway through the TGFβ2/ALK1 axis | Experimental & Molecular Medicine | 2022/10/12 |
Validation data
No data found
Associated products and services
Products & Service | Products & Service Information |
---|---|
AAV Packaging service | Detail |
Promise-ORF™ viral CDNA library | Detail |
Plasmid DNA Rapid Preparation Service | Detail |